Levothyroxine Sodium Tablet
Product Images NDC 59651-554

Product Visual Gallery

This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Levothyroxine Sodium (NDC 59651-554). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Aurobindo Pharma Limited, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Package Label-principal Display Panel (137 mcg (90 Tablets Bottle))

Each tablet contains Levothyroxine sodium USP 137 mcg (0.137mg) manufactured by Aurobindo Pharma USA, Inc. The tablets are made in India and should be stored between 15°C to 30°C (59°F to 86°F). They should be protected from light and moisture and dispensed in a tight, light-resistant container according to USP guidelines. The product information can be found in the full prescribing information. The tablets are not to be accepted if the seal over the bottle opening is broken or missing. The product is available in a package of 90 tablets with the NDC code 59651-554-90.*

FDA Label Image

Package Label-principal Display Panel (150 mcg (90 Tablets Bottle))

This is a description of Levothyroxine Sodium tablets with a strength of 150 micrograms (0.15 mg), distributed by Aurobindo Pharma USA, Inc. The tablets are prescription-only and each tablet contains Levothyroxine sodium USP. It is recommended to store the tablets at 20° to 25°C (68° to 77°F) with excursions permitted to 15°to 30°C (59° to 86°F) and protect them from light and moisture. Dispensing should be done in a tight, light-resistant container. Do not use if seal over the bottle opening is broken or missing.*

FDA Label Image

Package Label-principal Display Panel (175 mcg (90 Tablets Bottle))

Each tablet contains Levothyroxine Sodium USP 175 mcg (0.175 mg) and is distributed by Aurobindo Pharma USA, Inc. The usual dosage information can be found in the package insert. The tablets should be stored at 20-25°C (68-77°F), with excursions allowed to 15-30°C (59-86°F). It is important to protect the tablets from light and moisture and dispense them in a tight, light-resistant container as per USP guidelines. These details are useful for understanding the medication profile, dosage, storage, and distribution information.*

FDA Label Image

Package Label-principal Display Panel (200 mcg (90 Tablets Bottle))

This is a description of Levothyroxine Sodium tablets, USP, containing 200 mcg (0.2 mg) per tablet. The usual dosage and storage instructions are provided, including information on temperature and light exposure. The tablets are Rx only and come in a package of 90 tablets from AUROBINDO. The medication should be stored in a tight, light-resistant container. The manufacturer is Aurobindo Pharma USA, Inc., and the tablets are made in India. The package insert should be consulted for full prescribing information.*

FDA Label Image

Package Label-principal Display Panel (300 mcg (90 Tablets Bottle))

The text provides information about a tablet containing Levothyroxine sodium USP 300 mcg (0.3 mg) distributed by Aurobindo Pharma USA, Inc. The prescription medication is for oral use. Additional details include the storage conditions, NDC number, and instructions regarding dispensing and handling.*

FDA Label Image

Str (Levothyroxine Str)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.